Pronase-resistant low molecular weight stimulators for the activation of proacrosin to acrosin were found in rhesus monkey oviduct fluid collected before, during and after ovulation, but the presence of high concentrations of acrosin inhibitors before and after ovulation partly masked the stimulation in unfractionated fluid. This low molecular weight fraction of oviduct fluid had no detectable esterase or amidase activity by itself, and the stimulating factors were sensitive to digestion by hyaluronidase and chondroitin ABC lyase and were presumed to be glycosaminoglycans. Heparin and hyaluronic acid had similar effects. The presence of soluble glycosaminoglycans at the site of fertilization suggests that they may have a role in capacitation and fertilization. Acrosin (EC 3.4.21.10), an acrosomal serine proteinase, is essential for penetration of the zona pellucida by the spermatozoon during mammalian fertilization (see reviews: Fritz et al, 1975; Brown & Hartree, 1976; Morton, 1977; Stambaugh, 1978) , and this enzyme exists in the acrosome in a zymogen form called proacrosin. At some time before fertilization proacrosin is activated to acrosin (Meizel
Introduction
Proacrosin was extracted from ejaculated spermatozoa of rhesus monkeys (Macaca mulatta) by a procedure similar to that described by Polakoski & Parrish (1977) , but isolated sperm heads rather than whole spermatozoa were used for the extraction. The heads were isolated as previously described using sonication and low-speed sucrose density-gradient centrifugation (Stambaugh & Buckley, 1970) , with 50 mM-/?-aminobenzamidine added to both the sonication medium and sucrose gradients to inhibit autoactivation of proacrosin during isolation. Rhesus monkey spermatozoa were collected by electroejaculation and washed (3 times) with 0-9% (w/v) sodium chloride containing 50 mM-p-aminobenzamidine. The washed sperm pellet was dispersed in 4 volumes of 0-9% sodium chloride containing 50 mMp-aminobenzamidine, and the spermatozoa were disrupted by sonication for 1 min at 1 A, 0°C, using a Branson Model LS-75 sonifier with a micro tip. The suspension, in 0-5 ml aliquots, was layered on 10-35 ml linear sucrose gradients containing 65% sucrose at the bottom, and 5% sucrose at the top of the tube in 0-05 M-Tris-HCl buffer, pH 7-2, containing 50 mM-/>aminobenzamidine. After centrifugation at 160 g for 10 min, 5°C, head, midpiece, and tail fractions were collected from the bottom of the tube, and the head fractions were pooled and used for proacrosin extraction. Extraction of proacrosin was carried out at 5°C overnight with 10% glycerol containing 50 mM-p-aminobenzamidine, pH 3-0. The extracts were centrifuged at 27 000 g for 30 min, 4°C, and the soluble portion was frozen and pooled for further purification immediately before each set of experiments.
Proacrosin was purified from this pooled sperm head extract by an initial dialysis of the extract against 8 M-urea, pH 3-0, 5°C, for 6 h as described by Polakoski & Parrish (1977) . This step reversibly denatures the zymogen and removes low molecular weight proteins from the extract. The urea was then removed by an overnight dialysis against 0-25 M-glycine-HCl buffer, pH 3-4, at 5°C. After removal of the denatured proteins by centrifugation (30 000 g), proacrosin was further purified by ultracentrifugation at 216 000 g for 17 h, 5°C, in 0-146 µ to 0-584 M-sucrose gradients buffered with 0-25 M-glycine-HCl, pH 3-4. Rhesus monkey proacrosin sedimented in the region of 57 000 molecular weight proteins and appeared to be a single homogeneous fraction. The specific activities for each proacrosin and acrosin preparation are recorded in the tables.
Proacrosin was assayed by determining the amount of acrosin activity produced from the zymogen after autoactivation in 0-15 M-Tris-HCl buffer, pH 8-3. One proacrosin unit was equal to one acrosin unit after autoactivation. Acrosin activity was measured spectrophotometrically by following the hydrolysis of BAEE or . The esterolytic activity on BAEE was followed at 254 nm using a Gilford recording spectrophotometer at 25 ± 0-1°C by the procedure of Bergmeyer (1963) . A molar absorbance of 1150 m_1 cm-1 was used to calculate the amount (umol) of BAEE hydrolysed. The amidase activity of acrosin was measured spectrophotometricaUy at 410 nm, 25°C, with as the substrate, essentially by the procedure of Erlanger, Kokowsky & Cohen (1961) , using an extinction coefficient of 8800 for />-nitroaniline. The assay medium contained 9-38 -2 µ-in 0-05 M-Tris-HCl buffer, pH 8-2, containing 0-01 M-CaCl2 with a final assay volume of 3-2 ml after the addition of proacrosin or acrosin and the indicated test compounds.
Protein concentrations were determined by the procedure of Lowry, Rosebrough, Farr & Randall (1951) .
Rhesus monkey oviduct fluid was coUected as before (Stambaugh et al, 1974) by the continuous collection procedure of Mastroianni, Shah & Abdul-Karim (1961) using a refrigerated external collection chamber. Specimens were collected every 24 h before, during, and after ovulation.
The rate of proacrosin activation was measured at 4°C, in 0-025 M-Tris-HCl buffer,pH 7-0, containing 0-1 ml of the low molecular weight fraction of the oviduct fluid or the indicated quantities of glycosaminoglycan activators. The reactions were initiated by the addition of proacrosin at zero time, and 0-05-ml portions were removed for acrosin assays with BAEE or . The results are recorded as specific activities determined from the initial reaction rates of the assay. Pronase resistance of the stimulatory factor for proacrosin activation was demonstrated by incubating the oviduct fluid with pronase (100 ug/ml) before ultracentrifugation. Pronase sediments into the sucrose gradient during centrifugation at 216 000 g for 17 h and is removed from the low molecular weight fraction in the supernatant layer.
Results
Initial experiments with the low molecular weight fractions from oviduct fluid of preovulatory rhesus monkeys demonstrated a marked stimulation of the activation of proacrosin without loss of the sigmoidal curve characteristic of autoactivation of enzyme zymogens such as trypsinogen and proacrosin (Text- fig. 1 ). Incubation of 0-1 ml of the supernatant fraction (containing the low molecular weight fractions) after ultracentrifugation resulted in proacrosin activation within 5 to 10 min, a rate 5-6 times the autoactivation time without these fractions. This effect was greatly diminished if the fractions were preincubated with bovine testicular hyaluronidase or chondroitin ABC lyase, but not by pronase (Tables 1 and 2 ). Unfractionated oviduct fluid collected on the day of ovulation also markedly stimulated proacrosin activation, but unfractionated oviduct fluid collected 3 days before ovulation had a diminished stimulatory effect (Table 3) . The glycosaminoglycans heparin and hyaluronic acid also stimulated proacrosin activation (Tables 1 and 2) and the activation curve was always sigmoidal. Hyaluronidase or chondroitin ABC lyase pretreatment of the oviduct fluid fractions or hyaluronic acid greatly diminished the stimulatory activity of these substances but never completely eliminated the stimulatory effect.
Similar results were obtained when BAEE and were used to determine acrosin esterolytic and amidase activity, respectively. Control experiments using hyaluronidase or chondroitin ABC lyase in the absence of oviduct fluid or glycosaminoglycans demonstrated that these two enzymes had no effect on proacrosin activation by themselves. Neither the oviduct fluid fractions nor the glycosaminoglycans, heparin and hyaluronic acid, had any significant effect on fully activated acrosin preparations (Table 1) . (10 pg t Initial reaction rates with BAEE were taken after a 5-min activation period at 4°C. All proacrosin activation experiments with oviduct fluid were carried out with one proacrosin preparation (Group 1). The proacrosin activation experiments in Group 2 were performed with a second proacrosin preparation. Proacrosin alone LMF + proacrosin LMF pretreated with hyaluronidase (10 ug) + proacrosin LMF pretreated with chondroitin ABC lyase (5 pg) + proacrosin LMF without proacrosin Activated proacrosin (20 min, 25°C ).
2-1 IO'2 510 IO"2 24-3 IO"2 22-1 IO"2 0 522 IO"2 3-4 483 323 2-6 2-4 501 "2 -2 "2 "2 "2 "2 * In 0-15 M-Tris-HCl buffer, pH 8-3. t Initial reaction rates with were taken after a 5-min activation period at 4°C. All proacrosin activation experiments with oviduct fluid were carried out with one proacrosin preparation (Group 1). The proacrosin activation experiments in Group 2 were performed with a second proacrosin preparation. t Initial reaction rates with were taken after a 5-min activation period at 4°C. Discussion
The experimental results described here demonstrate that the low molecular weight fraction from rhesus monkey oviduct fluid contains one or more components that stimulate the conversion of purified proacrosin to acrosin. The active factor or factors in this fraction of oviduct fluid are sensitive to digestion by both hyaluronidase and chrondroitin ABC lyase, but not to pronase digestion. These results are simUar to those reported for porcine uterine washings by Wincek et al (1979) , who tentatively identified the stimulatory factor(s) as glycosaminoglycans. Unfractionated rhesus monkey oviduct fluid collected on the day of ovulation, when there are low concentrations of acrosin inhibitors (Stambaugh et al, 1974) , also markedly stimulated the rate of proacrosin activation, but the stimulatory effect of fluid collected before or after ovulation was not as great. This can be explained by the high concentrations of acrosin inhibitors before and after ovulation that would inhibit autoactivation, since the stimulatory effects of the supernatant fractions after ultracentrifugation are comparable regardless of the day of collection (Table 3 ).
The demonstration that the common glycosaminoglycans, heparin and hyaluronic acid, also stimulated the activation of primate proacrosin provides additional confirmation that the active components in oviduct fluid are probably glycosaminoglycans, and that the stimulatory effect is not highly specific for the glycosaminoglycan. The lesser stimulation by hyaluronic acid than by heparin suggests that the oviduct fluid stimulators may be sulphated glycosaminoglycans. Chondroitin ABC lyase and hyaluronidase destroyed most of the stimulatory effect of oviduct fluid and hyaluronic acid. The end products of exhaustive digestion of hyaluronic acid by testicular hyaluronidase are tetrasaccharides (90%) and disaccharides (10%). With chondroitin 4or 6-sulphates the main end products are disulphated tetrasaccharides (Weissman, Meyer, Sampson & Linker, 1954; Mathews & Inouye, 1961 ). Therefore, it seems possible that the active glycosaminoglycans of oviduct fluid may be sulphated oligosaccharides of unknown structure, but with polymer lengths greater than a tetrasaccharide. Since the sigmoidal shape of the activation curve is retained in the presence of the oviduct fluid-factors, heparin, or hyaluronic acid, the accelerating effect is apparently an acceleration of the autoactivation process. This conclusion is supported by the observations that none of these stimulators had any effect on the enzymic activity of completely activated acrosin preparations, and by the decreased stimulation of proacrosin activation when oviduct fluid containing high concentrations of acrosin inhibitors was used. The stimulation of proacrosin activation is probably, therefore, due to a direct interaction between proacrosin and the glycosaminoglycans. An effect of this type might be mediated by the binding and removal of an inhibitory polypeptide released from proacrosin as this zymogen is activated. Heparin has been reported to accelerate pepsinogen activation by binding a cationic inhibitory polypeptide released during pepsinogen conversion to pepsin (Harboe, Andersen, Foltmann, Kay & Kassell, 1974) , but the release of an inhibitory polypeptide from proacrosin has not yet been demonstrated (Brown & Hartree, 1975) . It is tempting to assign an essential role to glycosaminoglycans in the capacitation process of mammalian fertilization, since glycosaminoglycans are present in uterine and oviduct fluid as well as in the matrix of the cumulus oophorus surrounding the ovum. However, glycos¬ aminoglycans of uterine fluid may never contact the proacrosin of the acrosome since the acrosome reaction takes place in the oviduct and not in the uterus. A physiological role for the glycosaminoglycans now seems to be a definite possibility since they are present in the soluble portion of oviduct fluid at the time of ovulation and in the normal environment created by the oviduct for the acrosome reaction and fertilization. This study was supported by NIH grants HD-11600 and HDO-6274-07.
